Apr 06

Health Canada has initiated a safety review on Xeljanz and Xeljanz XR (tofacitinib), used to treat arthritis and ulcerative colitis

Add comments

Health Canada is informing Canadians and health care professionals that it is conducting a safety review of Xeljanz and Xeljanz…

Source

Read the full article. Click on the "original post by" author/publication link.


Comments are closed.